Go to Main

Analysis of hair loss patients' cells confirms hair follicle aging mechanism Published in ACS Nano... Demonstrates potential for Nanozyme therapy

A research team has discovered that the decline of peroxisomes is a key driver of hair loss.

On March 11, the research team led by Professor Eun-Jung Jin (CEO of Organelle Therapeutics Inc.) announced they have identified, for the first time in the world, that peroxisome dysfunction is a primary cause of hair follicle aging and subsequent hair loss. The significance of this discovery was recognized globally with its upcoming publication in ACS Nano (Impact Factor: 16.1), a prestigious international journal in the field of nanoscience.

The research team also explained that after developing and applying a next-generation catalyst nanozyme that mimics peroxisome function, they confirmed a superior hair regeneration effect compared to the existing treatment, minoxidil. It was found to be effective in inducing hair follicle regeneration while restoring damaged cellular metabolic balance.

"This research is significant because it moves beyond mere symptom relief," said Professor Eun-Jung Jin. "It presents the possibility of treating hair loss fundamentally by restoring cellular metabolism and organelle function."

Resource: https://www.kmib.co.kr/article/view.asp?arcid=0029511466